解读原发性中枢神经系统弥漫性大B细胞淋巴瘤的MRI表现:一种新的亚组视角
该回顾性队列纳入100例免疫功能正常的原发性中枢神经系统EB病毒阴性弥漫性大B细胞淋巴瘤患者,评估治疗前MRI特征,通过无监督层次聚类识别出4个影像亚组,并探索各亚组间无进展生存与总生存的差异。
要点
- 病灶多灶性占55%,幕上仅受累占66%,肿块样形态占75%,中位体积5.5 mL。
- T2信号以低信号为主(63%),增强以实性强化为主(74%)。
- 聚类识别4个影像亚组:经典型肿块型40%、脑脊液表面为主型22%、浸润型20%、非典型肿块型18%。
核心结论
- 研究更新了原发性中枢神经系统淋巴瘤的常规MRI特征,并识别出4个影像亚组,为未来分子相关研究和预后分层提供依据。
研究设计与样本
- 回顾性连续队列,纳入2010至2023年在本中心淋巴瘤单元就诊的100例免疫功能正常、病理确诊的原发性中枢神经系统EB病毒阴性弥漫性大B细胞淋巴瘤患者,均有活检前1.5T或3T脑MRI(含T1WI、T2WI、FLAIR、DWI及增强T1序列),由两名神经放射科医生独立评估病灶特征,采用无监督层次聚类识别影像亚组,并用Cox回归在预设模型中校正年龄、性别、国际结外淋巴瘤研究组评分和诱导方案后评估亚组与生存的关联。
关键影像表现/征象
- 病灶多灶性占55%,仅幕上受累占66%,幕上幕下均受累占28%,仅幕下受累占6%。
- 形态以肿块样为主(75%),中位体积5.5 mL(四分位距2.0-14.9)。
- 相对于脑皮质,T2信号低信号占63%、等信号占21%、高信号占16%;T1等信号占50%、低信号占44%、高信号占6%。
- 强化方式为实性强化74%、斑片状强化7%、闭合环状强化4%、实性-斑片混合强化15%。
- 层次聚类识别4个亚组:经典型肿块型40%(幕上、T2低信号、实性强化肿块)、脑脊液表面为主型22%(室管膜、脑室内或皮质-软脑膜定位伴均匀强化)、浸润型20%(小强化灶伴广泛T2/FLAIR高信号和血管周围强化)、非典型肿块型18%(大而不均匀病灶,富含坏死和出血)。
诊断标准与关键数值
- 采用无监督层次聚类基于影像特征将患者分为4个影像亚组,各亚组比例分别为经典型肿块型40%、脑脊液表面为主型22%、浸润型20%、非典型肿块型18%。
- 探索性分析显示校正后总生存在各亚组间存在差异(P = .02),脑脊液表面为主型和浸润型死亡率较高,非典型肿块型死亡率低于经典型肿块型。
临床应用与阅片要点
- 阅片时需关注病灶数目、定位(幕上/幕下、室管膜/脑室内/皮质-软脑膜)、形态(肿块样/浸润性)、T2信号相对皮质的高低、强化方式及有无坏死出血,以对应4个影像亚组。
- 脑脊液表面为主型和浸润型 pattern 在探索性分析中与较高死亡率相关,非典型肿块型与较低死亡率相关,可提示预后分层参考。
- 研究结论指出该分型为未来分子相关研究和预后分层提供依据。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: Primary central nervous system Epstein-Barr virus-negative diffuse large B-cell lymphoma (PCNSL) of immunocompetent patients is an aggressive extranodal lymphoma with challenging imaging features. In a large histopathologically confirmed cohort, we aimed to update conventional MRI characteristics of PCNSL, identify radiologic subtypes, and explore early survival differences across subgroups.
MATERIALS AND METHODS: We retrospectively evaluated the consecutive cohort of immunocompetent patients diagnosed with PCNSL who presented to our lymphoma unit between 2010 and 2023, enrolling patients with available prebiopsy 1.5T or 3T brain MRI including T1-weighted, T2-weighted, FLAIR, DWI, and postcontrast T1 sequences. Two neuroradiologists independently assessed lesion characteristics (number, location, morphology, volume, signal). Unsupervised hierarchical clustering was applied to identify radiologically homogeneous subgroups. Associations between subgroup and progression-free/overall survival were assessed using Cox regression in prespecified models adjusted for age, sex, International Extranodal Lymphoma Study Group score, and induction regimen.
RESULTS: We enrolled 100 patients (median age 63.9 years, 51% women). Lesions were multifocal in 55% and involved only supratentorial brain in 66%, both supratentorial and infratentorial compartments in 28%, and only infratentorial in 6%. Morphology was predominantly mass-like (75%). Median volume was 5.5 mL (interquartile range 2.0-14.9). Relative to brain cortex, T2 signal was hypointense in 63%, isointense in 21%, and hyperintense in 16%; T1 was isointense in 50%, hypointense in 44%, and hyperintense in 6%. Enhancement was solid in 74%, patchy in 7%, closed-ring in 4%, and mixed solid-patchy in 15%. Hierarchical clustering identified 4 subgroups according to radiologic characteristics: 1) classic mass-forming (40%): supratentorial, T2-hypointense, solidly enhancing masses; 2) CSF surface-predominant (22%): ependymal, intraventricular, or cortical-pial locations with homogeneous enhancement; 3) infiltrative (20%): small enhancing foci with extensive T2/FLAIR hyperintensity and perivascular enhancement; and 4) atypical mass-forming (18%): large, heterogeneous lesions enriched in necrosis and hemorrhage. Adjusted overall survival differed across subgroups in exploratory analyses (P = .02), with higher mortality in CSF surface-predominant and infiltrative patterns and lower mortality in the atypical mass-forming group compared with classic mass-forming.
CONCLUSIONS: This study updates MRI features of PCNSL and identifies 4 radiologic subgroups, offering a basis for future molecular correlations and prognostic stratification.
引用
- Bonacchi R, Calimeri T, Shashkin I, et al. Decoding MRI Presentation of Primary Central Nervous System Diffuse Large B-Cell Lymphoma: A Novel Subgroup Perspective. AJNR Am J Neuroradiol. 2026. PMID: 41771734. doi:10.3174/ajnr.A9274
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。